PEPTIDE
Verified ComparisonLast updated: 12 March 2026

Follistatin-344 vs IGF-1 LR3

Follistatin-344 blocks myostatin and activin signaling. IGF-1 LR3 is a long-acting insulin-like growth factor. Different muscle-growth mechanisms.

Compound A

Follistatin 344

Recovery

Evidence
4.0/ 5
B+

Compound B

IGF-1 LR3

Growth Hormone

Evidence
4.1/ 5
A−
Editor's note
Follistatin inhibits myostatin (loss of limiting factor); IGF-1 LR3 stimulates growth (gain of signal).
CriterionFollistatin 344IGF-1 LR3
MechanismMyostatin inhibition (de-repression)IGF-1 receptor agonism (direct)
Muscle-growth potencyVery high (preclinical)Very high (preclinical)
Bone/metabolic effectsSecondary (myostatin signaling)Broad (IGF-1 multi-tissue)
Preclinical depthHigh (myostatin models)High (IGF-1 models)
Systemic vs localizedCan be localized (injection)Systemic

Frequently asked questions

Both; complementary mechanisms (myostatin inhibition vs IGF-1 growth signaling).